Cargando…
Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics
In HIV epidemics of Sub Saharan Africa, the utility of HIV prevention efforts focused on key populations at higher risk of HIV infection and transmission is unclear. We conducted a phylodynamic analysis of HIV-1 pol sequences from four different risk groups in Abuja, Nigeria to estimate transmission...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534066/ https://www.ncbi.nlm.nih.gov/pubmed/28775893 http://dx.doi.org/10.1093/ve/vex014 |
_version_ | 1783253718316089344 |
---|---|
author | Volz, Erik M. Ndembi, Nicaise Nowak, Rebecca Kijak, Gustavo H. Idoko, John Dakum, Patrick Royal, Walter Baral, Stefan Dybul, Mark Blattner, William A. Charurat, Man |
author_facet | Volz, Erik M. Ndembi, Nicaise Nowak, Rebecca Kijak, Gustavo H. Idoko, John Dakum, Patrick Royal, Walter Baral, Stefan Dybul, Mark Blattner, William A. Charurat, Man |
author_sort | Volz, Erik M. |
collection | PubMed |
description | In HIV epidemics of Sub Saharan Africa, the utility of HIV prevention efforts focused on key populations at higher risk of HIV infection and transmission is unclear. We conducted a phylodynamic analysis of HIV-1 pol sequences from four different risk groups in Abuja, Nigeria to estimate transmission patterns between men who have sex with men (MSM) and a representative sample of newly enrolled treatment naive HIV clients without clearly recorded HIV acquisition risks. We develop a realistic dynamical infectious disease model which was fitted to time-scaled phylogenies for subtypes G and CRF02_AG using a structured-coalescent approach. We compare the infectious disease model and structured coalescent to commonly used genetic clustering methods. We estimate HIV incidence among MSM of 7.9% (95%CI, 7.0–10.4) per susceptible person-year, and the population attributable fraction of HIV transmissions from MSM to reproductive age females to be 9.1% (95%CI, 3.8–18.6), and from the reproductive age women to MSM as 0.2% (95%CI, 0.06–0.3). Applying these parameter estimates to evaluate a test-and-treat HIV strategy that target MSM reduces the total HIV infections averted by half with a 2.5-fold saving. These results suggest the importance of addressing the HIV treatment needs of MSM in addition to cost-effectiveness of specific scale-up of treatment for MSM in the context of the mixed HIV epidemic observed in Nigeria. |
format | Online Article Text |
id | pubmed-5534066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-55340662017-08-03 Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics Volz, Erik M. Ndembi, Nicaise Nowak, Rebecca Kijak, Gustavo H. Idoko, John Dakum, Patrick Royal, Walter Baral, Stefan Dybul, Mark Blattner, William A. Charurat, Man Virus Evol Research Article In HIV epidemics of Sub Saharan Africa, the utility of HIV prevention efforts focused on key populations at higher risk of HIV infection and transmission is unclear. We conducted a phylodynamic analysis of HIV-1 pol sequences from four different risk groups in Abuja, Nigeria to estimate transmission patterns between men who have sex with men (MSM) and a representative sample of newly enrolled treatment naive HIV clients without clearly recorded HIV acquisition risks. We develop a realistic dynamical infectious disease model which was fitted to time-scaled phylogenies for subtypes G and CRF02_AG using a structured-coalescent approach. We compare the infectious disease model and structured coalescent to commonly used genetic clustering methods. We estimate HIV incidence among MSM of 7.9% (95%CI, 7.0–10.4) per susceptible person-year, and the population attributable fraction of HIV transmissions from MSM to reproductive age females to be 9.1% (95%CI, 3.8–18.6), and from the reproductive age women to MSM as 0.2% (95%CI, 0.06–0.3). Applying these parameter estimates to evaluate a test-and-treat HIV strategy that target MSM reduces the total HIV infections averted by half with a 2.5-fold saving. These results suggest the importance of addressing the HIV treatment needs of MSM in addition to cost-effectiveness of specific scale-up of treatment for MSM in the context of the mixed HIV epidemic observed in Nigeria. Oxford University Press 2017-07-28 /pmc/articles/PMC5534066/ /pubmed/28775893 http://dx.doi.org/10.1093/ve/vex014 Text en © The Author 2017. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Volz, Erik M. Ndembi, Nicaise Nowak, Rebecca Kijak, Gustavo H. Idoko, John Dakum, Patrick Royal, Walter Baral, Stefan Dybul, Mark Blattner, William A. Charurat, Man Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics |
title | Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics |
title_full | Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics |
title_fullStr | Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics |
title_full_unstemmed | Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics |
title_short | Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics |
title_sort | phylodynamic analysis to inform prevention efforts in mixed hiv epidemics |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534066/ https://www.ncbi.nlm.nih.gov/pubmed/28775893 http://dx.doi.org/10.1093/ve/vex014 |
work_keys_str_mv | AT volzerikm phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics AT ndembinicaise phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics AT nowakrebecca phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics AT kijakgustavoh phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics AT idokojohn phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics AT dakumpatrick phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics AT royalwalter phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics AT baralstefan phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics AT dybulmark phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics AT blattnerwilliama phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics AT charuratman phylodynamicanalysistoinformpreventioneffortsinmixedhivepidemics |